Search Results - "Lucero, Olivia M."

  • Showing 1 - 20 results of 20
Refine Results
  1. 1

    The V-ATPase B1-subunit promoter drives expression of Cre recombinase in intercalated cells of the kidney by Miller, R. Lance, Lucero, Olivia M., Riemondy, Kent A., Baumgartner, Brett K., Brown, Dennis, Breton, Sylvie, Nelson, Raoul D.

    Published in Kidney international (01-02-2009)
    “…The collecting duct of the kidney is composed of two morphologically and physiologically distinct cell types, principal and intercalated cells. To better…”
    Get full text
    Journal Article
  2. 2

    Identification, genetic testing, and management of hereditary melanoma by Leachman, Sancy A., Lucero, Olivia M., Sampson, Jone E., Cassidy, Pamela, Bruno, William, Queirolo, Paola, Ghiorzo, Paola

    Published in Cancer and metastasis reviews (01-03-2017)
    “…Several distinct melanoma syndromes have been defined, and genetic tests are available for the associated causative genes. Guidelines for melanoma genetic…”
    Get full text
    Journal Article
  3. 3
  4. 4

    Tranexamic Acid Prevention of Hemorrhagic Complications Following Interpolated Flap Repair: A Single-Center, Retrospective, Cohort Study by Freeman, S. Caleb, Heath, Michael S., Neill, Brett, Morris, Caroline, Lucero, Olivia M., Yu, Wesley, Bar, Anna, Leitenberger, Justin J.

    Published in Dermatologic surgery (01-12-2023)
    “…Tranexamic acid (TXA) is increasingly being used to prevent hemorrhagic complications after dermatologic surgery. Interpolated flap repairs following Mohs…”
    Get full text
    Journal Article
  5. 5
  6. 6
  7. 7

    Single-Cell Identification of Melanoma Biomarkers in Circulating Tumor Cells by Fankhauser, Reilly, Chang, Matthew, Garrison, Zachary, Berryman, Rachel, Lucero, Olivia M, Fuiten, Allison, DePatie, Nicholas, Seifert, Hilary, Kulkarni, Rajan P

    Published in Cancers (01-10-2022)
    “…The current standard for investigating tumors is surgical biopsy, which is costly, invasive, and difficult to perform serially. As an adjunct, circulating…”
    Get full text
    Journal Article
  8. 8

    A Re-evaluation of the “Oncogenic” Nature of Wnt/β-catenin Signaling in Melanoma and Other Cancers by Lucero, Olivia M., Dawson, David W., Moon, Randall T., Chien, Andy J.

    Published in Current oncology reports (01-09-2010)
    “…In cancer, Wnt/β-catenin signaling is ubiquitously referred to as an “oncogenic” pathway that promotes tumor progression. This review examines how the…”
    Get full text
    Journal Article
  9. 9

    A case illustrating successful eradication of recurrent, aggressive basal cell carcinoma located in a scar with vismodegib by Lucero, Olivia M, Fitzmaurice, Sarah, Thompson, Curtis, Leitenberge, Justin

    Published in Dermatology online journal (15-02-2018)
    “…Vismodegib is a small molecule inhibitor of the Hedgehog signaling pathway that has shown efficacy in the control of locally advanced or metastatic basal cell…”
    Get full text
    Journal Article
  10. 10

    WNT5A enhances resistance of melanoma cells to targeted BRAF inhibitors by Anastas, Jamie N, Kulikauskas, Rima M, Tamir, Tigist, Rizos, Helen, Long, Georgina V, von Euw, Erika M, Yang, Pei-Tzu, Chen, Hsiao-Wang, Haydu, Lauren, Toroni, Rachel A, Lucero, Olivia M, Chien, Andy J, Moon, Randall T

    Published in The Journal of clinical investigation (01-07-2014)
    “…About half of all melanomas harbor a mutation that results in a constitutively active BRAF kinase mutant (BRAF(V600E/K)) that can be selectively inhibited by…”
    Get full text
    Journal Article
  11. 11
  12. 12
  13. 13

    CAR-NK Specific Targeting of Clonal Tcrvβ Chain to Treat T-Cell Non-Hodgkin's Lymphoma by Morris, Karen E, Bowman, Jenna, Lee, Ji-Ann, Tyner, Jeffrey W, Palazzolo, Mike, Druker, Brian J., Lydon, Nick, Bowers, Peter M, Lucero, Olivia M

    Published in Blood (02-11-2023)
    “…Background T-cell Non-Hodgkin Lymphoma (T-NHL) is a diverse group of aggressive malignancies which are minimally researched and have poorer patient outcomes…”
    Get full text
    Journal Article
  14. 14
  15. 15
  16. 16

    Abstract P32: CAR-NK Specific Targeting of Clonal TCRVβ Chain to Treat T-cell Non-Hodgkin's Lymphoma by Morris, Karen E, Bowman, Jenna, Lee, Ji-Ann, Tyner, Jeffrey, Palazzolo, Mike, Druker, Brian J, Lydon, Nick, Bowers, Peter M, Lucero, Olivia M

    Published in Blood cancer discovery (04-03-2024)
    “…T-cell Non-Hodgkin Lymphoma (T-NHL) is a diverse group of aggressive malignancies. Therapies are characterized by pan T-cell cytotoxicity, poor response rates,…”
    Get full text
    Journal Article
  17. 17

    Wnt/β-catenin signaling and AXIN1 regulate apoptosis triggered by inhibition of the mutant kinase BRAFV600E in human melanoma by Biechele, Travis L, Kulikauskas, Rima M, Toroni, Rachel A, Lucero, Olivia M, Swift, Reyna D, James, Richard G, Robin, Nick C, Dawson, David W, Moon, Randall T, Chien, Andy J

    Published in Science signaling (10-01-2012)
    “…Because the Wnt/β-catenin signaling pathway is linked to melanoma pathogenesis and to patient survival, we conducted a kinome small interfering RNA (siRNA)…”
    Get more information
    Journal Article
  18. 18
  19. 19
  20. 20